More than a third of eligible people benefit from PrEP because of HIV, but disparities persist
New preliminary data from the Centers for Disease Control and Prevention (CDC) shows that more than one-third of people who could benefit from pre-exposure prophylaxis (PrEP) for HIV have received a prescription for the drug. in 2022. Expanding PrEP use is a key part of CDC’s Ending the HIV Epidemic in the United States (EHE) … Read more